DEA Receives Application from Irvine Labs, Inc. to Manufacture Controlled Substances

Summary

The Drug Enforcement Administration (DEA) has received an application from Irvine Labs, Inc. to manufacture controlled substances in bulk, specifically those listed in Schedule I, and will evaluate it in accordance with its regulations governing marihuana research